David Luckey

Photo of David Luckey
Senior International / Defense Researcher; Professor of Policy Analysis, Pardee RAND Graduate School
Off Site Office


M.B.A., University of Maryland; M.S. in air and space strategic studies, University of Maryland; M.A. in national security affairs, Naval Postgraduate School; B.A. in American studies/military history, Purdue University

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email media@rand.org.

More Experts


David S. Luckey is a senior international and defense researcher at the RAND Corporation and a professor of policy analysis at the Pardee RAND Graduate School. He came to RAND from the Senate Committee on Homeland Security and Governmental Affairs where he was the director of Homeland Security and served as the counterterrorism advisor to the chairman. He directed oversight of and legislation for the Department of Homeland Security, and he advised the chairman daily on counterterrorism and homeland securityissues. Luckey was previously a senior professional staff member on the Senate Select Committee on Intelligence, where he led Audits and Oversight for the chairman and vice chairman. He was previously the senior policy analyst for the under secretary of Defense for Intelligence and a senior inspector in the Office of the Director of National Intelligence, Office of Inspector General. Luckey was also an operations analyst, test manager, and senior systems analyst supporting the Marine Corps Operational Test and Evaluation Activity, Navy Operational Test and Evaluation Force, Naval Special Warfare Command, and Naval Aviation community. A retired Marine Corps Officer and graduate of Air War College and Marine Corps Command and Staff College, Luckey holds an M.A. in national security affairs from the Naval Postgraduate School, and an M.S. in air and space strategic studies and M.B.A. from the University of Maryland.

Recent Projects

  • Commission on Combating Synthetic Opioid Trafficking
  • Capability Portfolio Assessment and Requirements Capability Analysis
  • Strategic Planning and Performance Management Support
  • Improving Intelligence Support to the Future Warfighter: Acquisition for the Contested Environment
  • Measuring Intelligence, Surveillance, and Reconnaissance Effectiveness

Selected Publications

Commission on Combating Synthetic Opioid Trafficking, Final Report, RAND (EP-68838), 2022

David Luckey, David Stebbins, Sarah W. Denton, Elena Wicker, Stephanie Anne Pillion, Alice Shih, National Geospatial-Intelligence Agency Resources: Financial Management Programming Evaluation, RAND (RR-A659-1), 2022

David Luckey, Bradley Knopp, Sasha Romanosky, Amanda Wicker, David Stebbins, Cortney Weinbaum, Sunny D. Bhatt, Hilary Reininger, Yousuf Abdelfatah, Sarah Heintz, Measuring Intelligence, Surveillance, and Reconnaissance Effectivenes at the United States Central Command, RAND (RR-4360-OSD), 2021

Cynthia R. Cook, David Luckey, Bradley Knopp, Yuliya Shokh, Karen M. Sudkamp, Don Casler, Yousuf Adbelfatah, Hilary Reininger, Improving Intelligence Support to the Warfighter, RAND (RR-A537-1), 2021

Bradley Knopp, David Luckey, Yuliya Shokh, Documenting Intelligence Mission-Data Production Requirements, RAND (RR-A241-1), 2021

David Luckey, David Stebbins, Rebeca Orrie, Erin Rebhan, Sunny D. Bhatt, Sina Beaghley, Assessing Continuous Evaluation Approaches for Insider Threats, RAND (RR-2684-OSD), 2019

George Nacouzi, J.D. Williams, Brian Dolan, Anne Stickells, David Luckey, Colin Ludwig, Jia Xu, Yuliya Shokh, Daniel M. Gerstein, Michael H. Decker, Assessment of the Proliferation of Certain Remotely Piloted Aircraft Systems, RAND (RR-2369-JS), 2018

Cortney Weinbaum, Bonnie, L. Triezenberg, Erika Meza, David Luckey, Understanding Government Telework, RAND (RR-2023-OSD), 2018

Recent Media Appearances

Interviews: Federal News Network


  • The Out of Harm's Reach organization distributes free kits containing fentanyl test strips and NARCAN nasal spray to attendees of FEST 19 in Gainesville, Florida, October 29, 2021, photo by Julia Cooper/Reuters

    Fentanyl Makes an Already Dangerous Drug Market Deadlier Than Ever

    Failure to recognize and respond to how rapidly illegal drug markets have changed with the arrival of illegally manufactured synthetic opioids will continue to put many Americans at risk of exposure to fentanyl, endangering the lives of hundreds of thousands more for years to come.

    May 2, 2022 The Ripon Forum

  • Boxes of naloxone spray and fentanyl test strips in a container at The Legionnaire bar in Oakland, California, March 3, 2022, photo by Nathan Frandino/Reuters

    A Greater Focus On Harm Reduction Will Save Lives

    For decades, elected officials brushed off harm reduction as a viable option for reducing the harms of drug use over concerns of enabling drug consumption. But now, these strategies are front and center, spoken aloud, from the largest podium in the land, and during prime time. What caused this historic about-face?

    Apr 29, 2022 Health Affairs Blog

  • David Luckey, senior international and defense researcher, and Jayme Fuglesten, director of Congressional Relations at RAND, on Capitol Hill, photo by Grace Evans/RAND Corporation

    A New Approach to Fighting Synthetic Opioids: Q&A with David Luckey and Jayme Fuglesten

    The opioid crisis isn't just about drug policy or law. It involves national security, homeland security, intelligence, diplomacy, supply chain issues, and cryptocurrency. Drawing on RAND's expertise across all those areas, the Commission on Combating Synthetic Opioid Trafficking delivered a plan, a call to action about what it's going to take to save lives.

    Apr 26, 2022

  • Tablets and powder under a magnifying glass, photo by Andrey Bukreev/Getty Images

    A New and More Dangerous Drug Market Requires a New Approach

    Synthetic opioids are likely to increasingly reach illegal drug markets. Failure to recognize and respond to how rapidly drug markets have changed with the arrival of illegally manufactured synthetic opioids will continue to put many at risk of exposure to fentanyl, endangering the lives of hundreds of thousands more Americans for years to come.

    Mar 16, 2022 The RAND Blog